Impact of a new combined immunosuppressive regimen on the one-year follow-up of kidney transplant patients : a cost-effectiveness analysis

Détails

Demande d'une copie
ID Serval
serval:BIB_464C9662A70E
Type
Mémoire
Collection
Publications
Titre
Impact of a new combined immunosuppressive regimen on the one-year follow-up of kidney transplant patients : a cost-effectiveness analysis
Auteur(s)
Kast-Brückner Mira
Directeur(s)
Wasserfallen Jean-Blaise
Editeur
IEMS (Institute of Health Economics and Management)
Institution
Université de Lausanne, Faculté des hautes études commerciales
Adresse
Lausanne
Statut éditorial
Acceptée
Date de publication
2006
Genre
Mémoire / Institute of Health Economics and Management ; no 98
Langue
français
Nombre de pages
26 f.
Notes
DESS en économie et management de la santé - Master in Health Economics and Management (MHEM) Mention de responsabiblité : / Mira Kast-Brückner ; [supervisor: Jean-Blaise Wasserfallen] SAPHIRID:62630
Résumé
[...] The objective of this study was to compare costs and efficacy of two different drug regimens in a Swiss hospital setting throughout the first year after renal transplantation: a new combined immunosuppressive and anti-infectious regimen and usual immunosuppression with anti-infectious prophylaxis reserved to high-risk patients. Thus, the main difference between the two drug regimens is the universal use of CMV [cytomegalovirus] prophylaxis for all patients. Applying the local cost structure, we compared resource use and direct short term costs associated with both hospital and outpatient care. We compared both regimens in terms of clinical outcomes, measured as the number of acute rejections and CMV infection episodes and related costs to clinical outcomes. [...] [Auteure p. 1-2]
Mots-clé
Kidney Transplantation , Immunosuppression , Cytomegalovirus Infections , Cost-Benefit Analysis , Hospitals, University
Création de la notice
14/03/2008 11:12
Dernière modification de la notice
03/03/2018 16:47
Données d'usage